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The equilibria that allow bacterial
persistence in human hosts
Martin J. Blaser1 & Denise Kirschner2
We propose that microbes that have developed persistent relationships with human hosts have evolved cross-signalling
mechanisms that permit homeostasis that conforms to Nash equilibria and, more specifically, to evolutionarily stable
strategies. This implies that a group of highly diverse organisms has evolved within the changing contexts of variation in
effective human population size and lifespan, shaping the equilibria achieved, and creating relationships resembling climax
communities. We propose that such ecosystems contain nested communities in which equilibrium at one level contributes to
homeostasis at another. The model can aid prediction of equilibrium states in the context of further change: widespread
immunodeficiency, changing population densities, or extinctions.
W
hen two organisms occupy the same habitat, a conflict
or a series of compromises ensues. Sometimes there
are elements of both, and interactions range from
a ‘cold-war’-type conflict to peaceful coexistence.
Many of the most intense conflicts are accidental (for example, when
a microbe finds itself in a niche (or host) to which it is unaccus-
tomed), and the interactions are often short term (leading to the
eradication of the microbe or the death of the host). More complex
are the relationships between hosts and microbes that have evolved
together, each with adaptations tied to the biology of the other, often
leading to nonlinear interactions1.
We focus on a specific class of such relationships, persistent infec-
tions, resulting from the pairing of a microbe and host that have
survived the challenges of co-habitation. It is a phenotype defined
by its success. Because these relationships are fundamentally different
compared with either accidental or short-term co-evolved interac-
tions, our goal is to clarify the key principles. The central concept we
explore is that persistence represents the evolved selection for balan-
cing host and microbial interests, resulting in an equilibrium that, by
definition, is long-term but not necessarily forever stable. We hypo-
thesize that maintenance of this equilibrium requires a series of
evolved, nested equilibria to achieve the overall homeostasis.
The framework of such persistence is illustrated by examination of
three bacterial species (Helicobacter pylori, Salmonella typhi and
Mycobacterium tuberculosis) that are human-specific, despite causing
well-recognized biological costs to their hosts2–4. These particular
host–microbial interactions are representative of different classes
of persistent infection (Fig. 1). We focus on bacterial infections of
humans because of their importance and because of the knowledge
already gained through their study5; however, the principles should
be general to other microbes and other hosts.
Relationships between persistent microbes and their hosts span
many spatial scales and timescales. At a microscopic timescale are
the individual elements of both microbe and host reactive cell
(immunocyte) populations, together with their intra-host evolution
and interactions. The mesoscopic (physiological/ecological) scale
involves population dynamics and interaction consequences for both
host and transmission. At the macroscopic scale, host evolutionary
changes occur1.
We propose that microbial persistence represents a co-evolved
series of nested equilibria, operating simultaneously on each of these
multiple scales, to achieve an overall homeostasis. The composite
equilibria of host and microbe may be considered as a ‘holobiont’6
(that is, organisms living together in symbiosis), regardless of
whether there is mutualism7. Such relationships would resemble
climax communities that have achieved stability under prevailing
conditions. In the following sections, we consider elements critical
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Figure 1 | Classes of microbial persistence. Because inter-host
transmission is required for obligate host-associated microparasites, our
model is organized according to transmission strategy. After microbial
acquisition, there can be early transmission until effective immunity
develops. For microbes able to resist immune elimination, late transmission
may occur via progressive infection (class 1), non-progressive infection with
carriage (class 2), or development of progressive infection in hosts with
declining immunity (class 3). H. pylori, S. typhi and M. tuberculosis are
representative human-associated microbes belonging to these three classes,
respectively. Early and late transmission are biological trade-offs.
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to the development of the equilibria, including generation of host
immunity and its neutralization by persistent microbes (microscale);
variation among populations of microbes and host cells (mesoscale);
the parameters that affect inter-host microbial transmission (macro-
scale); and most critically, the types of rules governing the equilibria.
Immunity and microbial escape
Immunity, defined as the resistance of a host to the endogenous
propagation of microbes, is mediated by innate or adaptive recog-
nition8. Innate mechanisms are based on selection of hosts recogniz-
ing stereotypical structures, whereas adaptive immunity involves
intra-host memory against encountered threats. Just as microbial
populations evolved mechanisms to regulate group activities (for
example, quorum sensing), processes evolved in hosts to regulate
their immunocyte populations. In addition to upregulatory net-
works, regulatory T cells (TR cells) have the ability to secrete chemical
signals that limit T-helper 1 (TH1) and TH2 cellular responses
9–11.
Dedicated TR cells
11,12 suppress auto-intolerance and limit the
immunopathogenesis accompanying infections, probably selected
by reducing tissue injury from infections9. The balance between TR
and T-effector cells affects infectious disease pathogenesis in indi-
vidual hosts and at specific life-cycle stages9.
By definition, persistent microbes have successful strategies to
sufficiently thwart host responses to gain a niche. Many such micro-
bial adaptations have been recognized, involving stealth, antigenic
variation and anti-defence strategies (Table 1). Host responses may
be narrow, with a single immune clone out-competing the others
(immunodominance), or broad, in which multiple immune clones
develop; efficient control of persistent infection correlates with nar-
row responses13,14.
However, there is a balance between microbial immune evasion
and maintaining growth fitness. The evolved microbial genome15–17
reflects the tensions between these selective pressures18,19. For
example, H. pylori both downregulates T-cell responses by secreting
VacA20, and upregulates mucosal signal transduction pathways by
injecting into epithelial cells a protein (CagA) with tyrosine phos-
phorylation domains interacting with host cellular kinases and
phosphatases21–23. Clonal variants within individual hosts differ in
the number of phosphorylation domains, affecting interaction
intensity24. The gene (cagY) encoding the injection system pilus
protein possesses complex repetitive DNA regions that undergo
intragenic recombination, creating antigenic variants25. Persistent




For host-adapted microbes, transmission to new hosts is required.
This concept is captured by the term R0, which quantifies the
transmission potential of a microparasite as the average number of
secondary infections occurring when a single infectious host is intro-
duced into a universally susceptible host population27. A simple way
to define R0 explicitly, on the basis of a standard model of epidemic
transmission28,29, is given by the equation:
R0 5 BN/(a 1 b 1 n),
where BN is the transmission rate (a function of the population size,
N), a is the rate of mortality owing to the microbe (a measure of
virulence), b is the rate of mortality in the host population independ-
ent of the microbe (a measure of lifespan), and n is the rate at which
hosts recover from the infection (a measure of immunity). In other
formulations of R0, although transmission rate is a function of B and
N, the size of the population becomes more determinative30. When
R0 . 1, microbial transmission is sustained; when R0 , 1, transmis-
sion goes to extinction.
The level of virulence is set by competition among microbes of the
same species, because they always have the same host population
number (N) at any given time. If the parameters of the R0 equation
are independent of one another, then the direction of evolution
would be away from virulence towards commensalism, as selection
would favour highly transmissible (BRlarge), persistent (nR0) com-
mensals (aR0) or symbionts (aR2large)29. However, if B and a are
directly (and positively) related, then selection could favour some
level of virulence (a . 0) in the microbial population27. The effects of
the introduction of myxoma virus to the rabbit population in
Australia provides experimental support for this scenario31.
There is further meaning to each of the terms of the R0 equation. In
much earlier times, when human populations were small32, N was
limiting, which selected against pathogens that had high mortality
(a) (Table 2). With the rise of civilization33,34, population growth,
crowding and improved transportation, the number and proximity
of susceptible hosts grew, which permitted more pathogenic organ-
isms to flourish. Similarly, host variation (for example, immuno-
deficiencies increasing microbial number) affects B (the rate of
transmission), thereby increasing R0.
The basis for a host–microbe equilibrium model
Microbial success in a host requires the ability to grow and overcome
the host’s defences. The microbe must be able to access sufficient
nutrients, overcome physical forces (such as the peristalsis of the
gastrointestinal tract) and thwart innate or adaptive host defence
molecules; these are host ‘signals’ to which the microbe must adapt.
Conversely, microbial metabolites, toxins and anti-defence mole-
cules, and physical adherence to host cells are microbial ‘signals’ to
the host. The host-derived and microbial-derived signals may be
either unlinked or linked. In the unlinked model, when the host wins,
the microbe is eliminated, but if the microbe wins, the host dies. An






Molecular mimicry Escherichia coli (K1 capsule)
Low antigenicity (surface antigen) Treponema pallidum
Low expression of stimuli of
innate responses
Salmonella typhi (Vi)
Antigen masking Neisseria gonorrhoeae
Variation Surface-exposed antigens Bacteroides fragilis
Borrelia burgdorferi
Anti-defence Antibody-absorbing Staphylococcusaureus(proteinA)
IgA protease Haemophilus influenzae
Inhibition of phagocytosis Staphylococcus aureus
Resistance to phagocyte killing Salmonella
Disarming macrophages Yersinia spp. (YOPs)
Killing of macrophages Mycobacterium tuberculosis
Disarming T cells Helicobacter pylori (VacA)
This Table is adapted from refs 52–54. YOPs, Yersinia outer proteins.
Table 2 | Ontogeny of microbe acquisition in human pre-history/history




Major source of microbial
transmission
Nature of immunity Example Persistence





Long-term carriers Containment but not
elimination
M. tuberculosis, S. typhi,
varicella-zoster virus
Latency
Recent (,10,000) Large societies (.500,000) Acutely ill persons Life long Measles No
Very recent (,200) .10 million Acute infection Serotype-specific Pandemic influenza No
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alternative model, based on linked signals between microbe and host,
implies selective pressure favouring co-evolved phenotypes35,36, and
is most applicable to persistent organisms (Fig. 2). In such a model,
the host sequesters the bacterium into a discrete compartment (for
example, the lumen of the gastrointestinal tract, the interior of a
gallstone, the centre of a granuloma) that is surrounded by respond-
ing host cells that do not permit the microbe to extend into adjacent
tissues35–39. A linkage between host and microbial signals and the
achievement of persistence implies that equilibrium (homeostasis)
has been reached.
The equilibrium model
To understand the principles permitting persistent equilibrium, we
developed deterministic mathematical models35,36. Although we used
H. pylori (Box 1) as the model organism, the underlying principles
should be broadly generalizable. The essential feature of the model is
that there must be both positive and negative feedback between the
host and microbe; only with negative feedback can equilibrium (per-
sistence) be achieved. The constructed model36 encompasses five
prototypic populations that are followed over time (Supplementary
Information). There are two microbial subpopulations: bacteria that
are free-living in the gastric mucus or are adherent to host cells. In a
broader sense, these two populations also represent any two classes of
bacterial cells that vary in the intensity of their host interactions. The
model also defined a concentration of microbial effector molecules
signalling the host, and a concentration of host-derived nutrients that
benefit the microbes. Finally, the model included host immunity,
governed by its response rate, ultimate capacity and the differential
effect of the two microbial subpopulations with high or limited inter-
action. In this model, immunity limits microbial populations by
restricting growth rates; immunity can be defined as lowering net
microbial replication. By limiting replication, the autoregulatory
network leads to either transient or persistent H. pylori coloniza-
tion36. This model produced equilibrium solutions under a wide
range of relevant biological variation. We propose that host status
is also critical in determining the types of equilibrium reached with S.
typhi (Box 2) and M. tuberculosis (Box 3).
Strain variation and the control of cheaters
The equilibrium model predicts that each microbial phenotypic vari-



































Figure 2 | A model for microbial persistence in metazoan hosts.
a, Schematic with model elements. After founding microbes are acquired,
new populations/population structure reflect intra-host adaptation,
influenced by both intermicrobial selection (a product of microbial
competition and cooperativity) and by the population of host reactive
(immune) cells, which determine the resource space and structure. A parallel
phenomenon describes the selection of host reactive cell populations. Events
within the host are inside the dashed box. These microevolutionary events
represent the first (microscopic) scale of the interaction (as adapted from ref.
1). For persisting organisms, these two interlocking phenomena have co-
evolved and in their sum affect secondary tissue functions (for example,
immune adjuvancy, hormone levels) that affect microbial transmission.
These second scale (mesoscopic) interaction events influence host viability
(for example, pathogens, through disease, or symbionts via resistance to
pathogens or to famine). On the macroscopic (host evolutionary)
interaction timescale, these events affect host population structure, which
then governs microbial transmission and selection for host genotypes
(shown by dotted lines). In this model, host population size and structure
are important selectors for the types of microbes that can be successful.
b, General schematic of the model. (See text for further discussion of
elements A–F.)
Box 1 jModel 1: Helicobacter pylori
Helicobacter pylori, a Gram-negative bacterium that colonizes the
human stomach as its sole environmental niche23, has redundant
(faecal–oral, oral–oral, vomitus–oral) transmission routes and notable
biological success: (1) present in humans for .50,000 yr; (2)
cosmopolitan (world-wide) in distribution; (3) nearly universal in all
developing societies; (4) colonization essentially life-long; (5)
dominant single species (.70% of clones) in the human stomach; and
(6) multiple strains often colonizing the same host55–60. Once
established in a host, H. pylori populations develop persistence, often
life-long, with concomitant host responses. Although H. pylori
enhances risk for lethal gastric cancer and peptic ulceration, these
generally occur late in life2. Equilibrium involves stimulating host
inflammation to provide nutrients35–37. Although H. pylori actively
replicates in the human stomach for decades, persistence eventually
may lead to progressive gastric atrophy61, which reduces or eliminates
its own colonization; thus, too much inflammation is maladaptive.
H. pylori has many characteristics favouring gastric colonization, out-
competing other microbes, and regulating and reducing specific
immune responses20,62–64. Adaptive H. pylori genomic features include
pathogenicity islands and numerous contingency genes65, with variable
expression based on binary switches16. On the basis of endogenous
mutation and recombination58, facilitated by natural competence for
DNA uptake66, H. pylori cells have high genomic plasticity, providing
numerous phenotypic variants capable of colonizing diverse and
changing niches40. Within-host dynamics between H. pylori
competition67 and cooperation40 are an important tension (microscopic
scale); success at this level provides one basis for the next stratum of
equilibrium (Fig. 2), and the emergence of phenotypic variants24,25
interacting with immunocytes26 provides another basis.
At mesoscopic and macroscopic scales, the success of H. pylori in
human populations reflects either low virulence or possible symbiosis
early in life; essentially all of its negative consequences occur after
reproductive age. Potential H. pylori benefits to young hosts include
protection against diarrhoeal diseases and asthma, and metabolic
regulation via gastric leptin and ghrelin23,68–70.
Consistent with an ESS, host population structure influences H. pylori
transmission. The family has been central71, with early transmission
opportunities from infected children72, especially older siblings, later
opportunities when girls become mothers (less so, but present from
fathers), and later still, as an old age consequence of gastric atrophy
and hypochlorhydria73 (class 1 in Fig. 1). With low H. pylori virulence,
there is little competition between early and late transmission (Fig. 1).
Gastric H. pylori colonization is a prototypic ESS, as it effectively
controls H. pylori cheaters, and essentially excludes all other bacteria
from the stomach56 for the bulk of an individual’s life, well into the post-
reproductive years, with probable early life benefits and little cost to
hosts. However, the use of antibiotics in the 20th century may have
eliminated an ESS that has existed since time immemorial.
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arise through mutation, intragenomic recombination, or horizontal
gene transfer40,41. When hosts harbour more than one strain simul-
taneously, these compete, but often also cooperate (through genetic
exchange and specialized function)42,43. The model indicates that for
competitors to persist, each must occupy an exclusive niche, or face
eventual elimination35,36. An implicit limitation of an equilibrium
model is the emergence of individuals (‘cheaters’) that break the rules
to their own advantage44.
Game theory provides solutions for how nature can resolve this
dilemma. A cheater may be defined as a player that changes strategy
unilaterally. A Nash equilibrium is a strategy profile in a game
with $2 players in which none can gain by changing strategy unilat-
erally45. A subset of the Nash equilibrium is the evolutionarily stable
strategy (ESS)46,47, which when present in a population resists inva-
sion by a competing alternative strategy. We propose that co-evolved
persistent microbe–host systems have developed ESSs, which pre-
clude cheater success.
What boundaries would ensure ESS maintenance? Because the
persistence model is based on linked regulation of host and microbial
signals, a cheater is a variant signalling for resources but not halting
its growth when the resources are provided, as the equilibrium
requires. One solution to this problem is that penalties for transgres-
sion have evolved in the ESS that ultimately lower cheater fitness.
Penalties can involve crossing thresholds to induce new host res-
ponses. A host response whereby bacterial growth triggers new innate
or adaptive responses with subsequent amplification would be effec-
tive, as any growth advantage for the cheater would be temporary
and local. Because a novel mutant can escape the specific immunity
directed towards a predominant strain, ecosystem stability might
favour microbes with low mutation rates48. However, the penalty
mechanism, affecting all strains of the microbe including cheaters,
does not permit mutational escape. Regulatory T cells are a class of
immunocyte that could closely modulate host responses to microbial
perturbations9–11, but multiple mechanisms exist (Supplementary
Information).
A general model of microbial persistence in hosts
Despite the enormous microbial variation that exists, our prior
mathematical modelling and examination of three cases of microbial
persistence (Boxes 1–3) indicate that a general hypothesis for persis-
tence in metazoan hosts can be developed. In complex ecosystems,
such as within humans, the model depends on a series of evolved
equilibrium relationships, nested in one another and interconnected,
and operating simultaneously over three different biological scales.
The model proposed represents an ESS, and has six major compo-
nents (identified as A–F; Fig. 2).
Element A represents the microbial populations persisting in a
particular tissue or host compartment (Fig. 2a). The composition
and structure of the population is based on the founding popula-
tions, the intra-host generation of variation, the selection imposed
by the competing (and cooperating) microbes, and the selection
Box 2 jModel 2: Salmonella typhi
Unlike all other known Salmonella species, S. typhi and the closely
related S. paratyphi A are obligate pathogens of humans74. Because
transmission is faecal–oral (often with food or water intermediates),
the ability of S. typhi to enter the faecal stream by thwarting host
phagocyte function75,76 is critical. Under conditions of poor hygiene, S.
typhi can infect large populations, but as those who survive natural
infection (about 80%) develop permanent immunity, the pool of
susceptible hosts is rapidly exhausted. However, some hosts become
asymptomatic biliary carriers (for example, ‘Typhoid Mary’), capable
of life-long S. typhi transmission. Although the humoral and cellular
immunity that develops77,78 protects these hosts from disease, it is
insufficient to sterilize the lumen of the gallbladder and biliary tract,
especially when gallstones are present79; the stone becomes the
segregated niche that enables life-long S. typhi carriage (class 2 in
Fig. 1).
Genomic analysis of S. typhi has provided tools to understand its
evolution80. The ancestral S. typhi haplotype arose after human
migrations out of Africa (50,000 yr BP), but before the Neolithic period
(10,000 yr BP)74,81, when effective human population sizes were
relatively small. Long persistence of individual haplotypes, neutral
population structure and global transmission74 are population
correlates of a stable lifestyle with high biological success. S. typhi
isolates show low genomic variation74,80 consistent with stable
immune interactions at the microscopic scale (Fig. 2). The effects of S.
typhi on biliary tract function (mesoscopic scale) with stable carrier
state development increase mean inter-host transmission time,
allowing for spread within and between human groups when small
populations were insufficient to sustain direct spread of acute
infection. The long-term carrier keeps S. typhi extant in a population
until new generations of susceptible hosts can be introduced to the
organism (macroscopic level). As human populations grew along
rivers33,34, faecal contamination of portable water by a carrier could
transmit S. typhi to distant downstream communities. Spread from
carriers initiates epidemic cycles, seeding populations for generations
to come.
Box 3 jModel 3: Mycobacterium tuberculosis
Mycobacterium tuberculosis, the cause of tuberculosis, is usually
transmitted from diseased hosts via cough-borne aerosols82. Once
acquired by the respiratory route, M. tuberculosis establishes a
pulmonary parenchymal focus, but in most hosts, life-long latency
develops, with low likelihood for disease. This raises the question of
how latency is established.
The essential site for M. tuberculosis persistence is within the
granuloma, a complex structure of bacteria and host multinucleated
cells and infected macrophages, encircled by both activated and non-
activated macrophages and T cells. The granuloma has a central
caseous necrotic core that harbours mycobacteria and dead host
cells83,84. In this environment, host cells and mycobacteria can interact for
the host’s lifetime85, with bacterial replication86,87 but controlled growth.
Mathematical models88–93 of the conditions favouring latency have
defined two bacterial subpopulations (intracellular and extracellular)
with distinctive growth rates and signals to host cells, and different
macrophage-response states and T-cell and cytokine contributions92. An
equilibrium maintains low bacterial levels and controls tissue damage,
based on macrophage activation and control83,84,93. This is the locus for
the microscopic scale of the general model (Fig. 2).
The models predict that disease reactivation occurs when the
granulomas no longer effectively control extracellular bacterial growth;
when intracellular management predominates, local tissue damage
and bacterial dissemination are reduced. The models also predict that
the signalling that occurs between host cells and their intracellular
bacteria facilitate granuloma maintenance, and that the slow
mycobacterial growth rate favours latency85,88–91,93. Thus, M.
tuberculosis has evolved slow growth rates and the ability to survive
inside macrophages, while hosts who minimize tissue damage from
potentially over-zealous immune responses have been selected75,83,85.
However, with ageing or other immunodeficiencies, infection within
the granuloma is no longer suppressed, net bacterial growth
accelerates, and disease occurs (mesoscopic scale)82,94. This
‘reactivation’ form of tuberculosis is most common, creating new
opportunities for transmission via coughing, often decades after the
organism was acquired (class 3 in Fig. 1). With both early and late
transmission possibilities, M. tuberculosis can skip generations of
human hosts, an effective strategy for host populations of small size
(macroscopic scale). The global population structure of M. tuberculosis,
defined by phylogeographic lineages associated with sympatric human
populations95, provides evidence for its co-evolution with humans, as
does the disproportion of allopatric tuberculosis cases involving
compromised hosts96. That host population characteristics determine
the extent of clinical tuberculosis in a community97 is consistent with
the remarkable genomic conservation of M. tuberculosis17,98. As
predicted, certain ‘cheater’ events, such as utilization of forbidden sites
(for example, development of tuberculous meningitis), cause host
demise without transmission; strains exhibiting such phenotypes
would be selected against.
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imposed by the host. The composition and population structure of
the reactive host cells involved in innate and adaptive immunity
(element B) is based on principles parallel to those governing the
microbial cells (founders, variants generated, selective pressure from
competing/cooperating cells) and the selection exerted by the per-
sisting microbes. Thus, the two populations (A and B) are inter-
dependent, and exist in a linked dynamic equilibrium.
The nature of this primary (microscale) host–microbial equilib-
rium shapes tissue function (element C, mesoscale), which ultimately
affects both host viability (element D, macroscale) and microbial
transmission (element F, mesoscale). Pathogenic microbes damage
tissue, leading to coughing, vomiting or diarrhoea, favouring their
own transmission. Conversely, the tissue effects of symbionts are
protective (for example, metabolic or immune), selecting for the
hosts that carry them.
The (negative or positive) effects on host viability select for host
genes in elements B and C, influencing population structure (element
E), which through extinction vortices also affects the host gene pool
(elements B and C). The host population structure affects microbial
transmission (element F), influencing the founding microbial popu-
lations in new hosts; small host population size selects against viru-
lence, and short lifespans select against late-transmitting microbes.
This is a dynamic model of co-evolved hosts and microbes
(Fig. 2b), requiring multiple scales, flexible across a range of condi-
tions, and useful for understanding both symbionts and pathogens.
In reality, there is no fixed distinction between the two; their bio-
logical behaviour is defined by their ecological context.
Discussion
Microbial transmission—central to the maintenance of persistent
host-adapted infections—is considered as being vertical across gen-
erations or horizontal across populations. Typically, indigenous
(commensal) organisms are transmitted vertically from mother to
child, whereas pathogens are transmitted horizontally. However,
there are intermediate cases49, because an individual is more likely
to cough on family members than on strangers, and the microbes
transmitted from mother to offspring may be affected by her envir-
onmental exposures. R0 dynamics can be affected by mixed vertical
and horizontal transmission, as well as by demographic changes, such
as number of births per woman.
Transfer of a microbe to a host genetically related to the previous
host occurs with vertical, but not necessarily horizontal, transmis-
sion; as pandemic infections become more frequent in the modern
world, horizontal transmission has an enhanced role. Microbial gen-
omes are plastic, with extensive intra-host variation37,38; strains partly
adapted to a new host owing to passage through a genetically related
previous host may yield different outcomes than strains from unre-
lated persons50.
As predicted by the R0 equation, with small effective population
sizes the long hunter-gatherer stage of human evolution was a bottle-
neck for highly virulent human pathogens. Small population sizes
selected for symbionts or for pathogens that could be transmitted
decades after infecting a host, after new susceptible individuals had
been introduced into the population via births (Table 2). In contrast,
high-virulence pathogens would have been driven to extinction by
the demise of their isolated host populations. However, with the
larger effective population sizes that have developed since the rise
of agriculture33,34, more virulent pathogens have been appearing. Our
rapidly changing human context, including widespread immuno-
deficiencies and jet travel, is continuing to alter the selection for
human-adapted microbes.
For example, the proportion of hosts newly infected with M. tuber-
culosis who develop progressive tuberculosis and become immedi-
ately infectious, who reactivate the infection late, or who never
reactivate, is dependent on the immunocompetence of the host
population. Host characteristics unevenly distributed across the
population, including malnutrition and HIV infection, affect the
proportions of individuals in each compartment and thus, the trans-
mission profiles. Similarly, because tuberculosis reactivation rates
are age-dependent, general improvements in health that lead to
increased proportions of elderly persons in the population affect
outcomes. Conversely, reactivation of lethal infections tends to
keep overall host lifespan under close regulation. Nevertheless, for
microbes like M. tuberculosis, there is also a cost to latency, because
competing mortality limits transmission. As HIV has become more
common, there has been selection towards progressive primary
tuberculosis.
As illustrated by M. tuberculosis, the evolution of a persistent para-
site that uses latency as part of its transmission strategy integrates the
transmission rates for all stages in the host life cycle, keeping net
R0 . 1. The balance between early and late opportunities for trans-
mission is context specific, dependent on host variables including
effective population size, age structure, distribution of immunocom-
petence and previous selection for resistance. Similarly for sym-
bionts, context matters. A microbe that induces iron deficiency
may be symbiotic in regions where malaria is holoendemic51, but
without malaria may decrease host fitness. Because context is all-
important in evolution, the multiple scales on which persistent
parasitic and symbiotic infections operate provide substrate for the
dynamic solutions that unfold.
We propose a new model based on ESSs, a subset of Nash equi-
libria, to explain the common features of microbial persistence in
their human hosts. That the model was consistent with the observed
biology of three bacteria (H. pylori, S. typhi and M. tuberculosis) with
highly dissimilar genomic and lifestyle features supports its genera-
lizability. Importantly, the model applies to both pathogens and
commensals, and can be used to understand the direction of viru-
lence as the context of human ecology changes.
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